Table 2.
|
NISDIa |
PACTG 219C3 |
||
---|---|---|---|---|
Category | N=731 | Percent (95% CI)b | N=2767 | Percent (95% CI)b |
Overall first infections | 568 | 77.7 (74.7–80.7) | Not reported | |
Bacterial pneumonia | 384 | 52.5 (48.9–56.2) | 698 | 25.2 (23.6–26.8) |
Oral candidiasis | 212 | 29.0 (25.7–32.3) | 761 | 27.5 (25.8–29.2) |
Varicella | 161 | 22.0 (19.0–25.0) | 395 | 14.3 (13.0–15.6) |
Tuberculosis | 65 | 8.9 (6.8–11.0) | 17 | 0.6 (0.3–0.9) |
Herpes zoster | 63 | 8.6 (6.6–10.6) | 280 | 10.0 (9.0–11.2) |
Pneumocystis jiroveci | 61 | 8.3 (6.3–10.3) | 79 | 2.9 (2.2–3.5) |
Diarrhea, proven | 56 | 7.7 (5.7–9.6) | 104 | 3.8 (3.1–4.5) |
Molluscum contagiosum | 56 | 7.7 (5.7–9.6) | 151 | 5.5 (4.6–6.3) |
Abscess, bacterial | 48 | 6.6 (4.8–8.4) | 5 | 0.2 (0.0–0.3) |
Bacteremia/septicemia | 48 | 6.6 (4.8–8.4) | 220 | 8.0 (6.9–9.0) |
Dermatophyte infections | 46 | 6.3 (4.5–8.1) | 422 | 15.3 (13.9–16.6) |
Urinary tract infections | 44 | 6.0 (4.3–7.7) | 68 | 2.5 (1.9–3.0) |
Lymphadenitis | 40 | 5.5 (3.8–7.1) | 11 | 0.4 (0.2–0.6) |
Lymphoid interstitial pneumonitis | 39 | 5.3 (3.7–7.0) | 325 | 11.8 (10.6–13.0) |
Herpes simplex | 27 | 3.7 (2.3–5.1) | 24 | 0.9 (0.5–1.2) |
Bacterial meningitis | 23 | 3.1 (1.9–4.4) | 13 | 0.5 (0.2–0.7) |
Viral hepatitis | 15 | 2.1 (1.0–3.1) | 60 | 2.2 (1.6–2.7) |
Cytomegalovirus not retinitis | 11 | 1.5 (0.6–2.4) | 49 | 1.8 (1.3–2.3) |
Esophageal/pulmonary candidiasis | 10 | 1.4 (0.5–2.2) | 39 | 1.4 (1.0–1.9) |
Toxoplasmosis (CNS) | 9 | 1.2 (0.4–2.0) | 5 | 0.2 (0.0–0.3) |
Cytomegalovirus retinitis | 6 | 0.8 (0.2–1.5) | 10 | 0.4 (0.1–0.6) |
Measles | 5 | 0.7 (0.1–1.3) | 5 | 0.2 (0.0–0.3) |
NISDI also reported three cases of progressive multifocal leukoencephalopathy, two cases of bacterial osteomyelitis, and one each of Cryptosporidium and encephalitis.
Higher reporting of specific infections between cohorts shown by bolded nonoverlapping intervals.